Which has the lower trailing P/E, ABBV or BMY?

BMY has the lower trailing P/E: ABBV trades at 72.43 and BMY at 14.02. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ABBV or BMY?

Over the past five years, ABBV grew revenue faster — ABBV at a 3.69% CAGR versus BMY at 2.08%.

Does ABBV or BMY pay a bigger dividend?

ABBV yields 2.68% and BMY yields 3.94% based on trailing dividends and the latest price.

Is ABBV or BMY more profitable?

BMY runs the higher net margin — ABBV at 9.81% versus BMY at 18.87%.

How have ABBV and BMY total returns compared?

Over the past 10 years, ABBV delivered 19.76% and BMY delivered 5.01% annualized total return. Past performance doesn't predict future results.

AbbVie Inc. (ABBV) vs Bristol-Myers Squibb Company (BMY)

A side-by-side comparison of AbbVie Inc. and Bristol-Myers Squibb Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.

ABBV

AbbVie Inc.

$454.17B

$257.06HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

BMY

Bristol-Myers Squibb Company

$130.00B

$63.64HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

Total return — ABBV vs BMY

growth of $100 · dividends reinvested · last 10y

ABBV +507.0% (+19.8%/yr)BMY +60.4% (+4.8%/yr)ABBV compounded faster over this window

ABBV BMY

ABBV vs BMY: by the numbers

•ABBV is the larger company ($454.17B vs $130.00B market cap).
•BMY trades at the lower trailing earnings multiple (14.02 vs 72.43 P/E), one valuation lens rather than an overall verdict.
•BMY converts more revenue to profit (18.87% vs 9.81% net margin).
•ABBV grew revenue faster over the past five years (3.69% vs 2.08% CAGR).
•BMY pays the higher dividend yield (3.94% vs 2.68%).

Metrics side by side

Valuation

Metric	ABBV	BMY
P/E ratio	72.43	14.02
Forward P/E	18.32	9.18
P/S ratio	7.05	2.64
P/B ratio	N/A	5.82
EV / EBITDA	19.34	9.71
FCF yield	3.99%	8.80%

Profitability

Metric	ABBV	BMY
Gross margin	71.48%	70.16%
Operating margin	29.32%	28.27%
Net margin	9.81%	18.87%
ROE	N/A	41.59%
ROIC	13.46%	15.47%

Dividends

Metric	ABBV	BMY
Dividend yield	2.68%	3.94%
Payout ratio	192.43%	55.29%

Growth (annualized)

Metric	ABBV	BMY
Revenue CAGR (5Y)	3.69%	2.08%
EPS CAGR (5Y)	-2.79%	9.38%
FCF CAGR (5Y)	0.11%	-0.95%
Total return CAGR (5Y)	23.51%	4.39%

Frequently asked

Which has the lower trailing P/E, ABBV or BMY?: BMY has the lower trailing P/E: ABBV trades at 72.43 and BMY at 14.02. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ABBV or BMY?: Over the past five years, ABBV grew revenue faster — ABBV at a 3.69% CAGR versus BMY at 2.08%.
Does ABBV or BMY pay a bigger dividend?: ABBV yields 2.68% and BMY yields 3.94% based on trailing dividends and the latest price.
Is ABBV or BMY more profitable?: BMY runs the higher net margin — ABBV at 9.81% versus BMY at 18.87%.
How have ABBV and BMY total returns compared?: Over the past 10 years, ABBV delivered 19.76% and BMY delivered 5.01% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABBV analysis Full BMY analysis Interactive comparison tool

Dig into the metrics

AbbVie P/E ratio Bristol-Myers Squibb P/E ratio AbbVie dividend yield Bristol-Myers Squibb dividend yield AbbVie ROE Bristol-Myers Squibb ROE AbbVie operating margin Bristol-Myers Squibb operating margin AbbVie revenue growth Bristol-Myers Squibb revenue growth AbbVie free cash flow Bristol-Myers Squibb free cash flow

AbbVie & Bristol-Myers Squibb appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest ROE Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.